HL Financial Services’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
$748K Buy
+8,324
New +$721K 0.01% 425
2017
Q3
Sell
-4,450
Closed -$495K 683
2017
Q2
$495K Sell
4,450
-200
-4% -$21.1K 0.01% 468
2017
Q1
$457K Sell
4,650
-24
-0.5% -$2.29K 0.01% 473
2016
Q4
$430K Sell
4,674
-200
-4% -$17.2K 0.01% 486
2016
Q3
$412K Hold
4,874
0.01% 478
2016
Q2
$397K Buy
4,874
+200
+4% +$15.2K 0.01% 481
2016
Q1
$334K Sell
4,674
-3,759
-45% -$252K 0.01% 509
2015
Q4
$600K Buy
8,433
+3,767
+81% +$253K 0.02% 404
2015
Q3
$287K Buy
4,666
+109
+2% +$7.62K 0.01% 532
2015
Q2
$330K Sell
4,557
-188
-4% -$13.9K 0.01% 541
2015
Q1
$365K Buy
4,745
+408
+9% +$29.2K 0.01% 523
2014
Q4
$291K Sell
4,337
-897
-17% -$56.6K 0.01% 561
2014
Q3
$318K Buy
5,234
+807
+18% +$49.7K 0.01% 534
2014
Q2
$260K Buy
+4,427
New +$259K 0.01% 597

Other funds holding DGX

HL Financial Services's DGX Position: Q1 2019 in Review

HL Financial Services opened a new position in Quest Diagnostics (DGX) in Q1 2019: 8,324 shares worth $748K. The stake represents 0.01% of the portfolio and ranks #425 among its holdings. This is a return to the name: HL Financial Services previously reported a position in DGX as recently as Q2 2017.

HL Financial Services first reported a position in DGX in Q2 2014 and has held it in 14 quarters since. 656 funds tracked by Wall St. Rank hold DGX as of Q1 2019.

  • HL Financial Services held 8,324 shares of Quest Diagnostics worth $748K as of Q1 2019.
  • Quest Diagnostics was a new HL Financial Services position in Q1 2019.
  • Quest Diagnostics made up 0.01% of HL Financial Services's portfolio in Q1 2019, its #425 holding.
  • HL Financial Services first reported a position in Quest Diagnostics in Q2 2014 and has held it in 14 quarters since.
  • 656 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2019.

Based on HL Financial Services's 13F filing for Q1 2019, filed 1 May 2019.